Clinical Trials in Texas

Showing 8121-8140 of 15,101 trials

Maxigesic IV Phase 3 Bunionectomy Study

NCT02689063

The purpose of the study is to determine the clinical efficacy and safety of Maxigesic IV, acetaminophen IV, Ibuprofen IV versus placebo IV for the treatment of acute postoperative pain after bunionectomy

Post Operative Pain

AFT Pharmaceuticals, Ltd.276 participantsStarted Oct 2016

Pasadena, Maryland, United States • Austin, Texas, United States

COMPLETEDPhase 355 miles

A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

NCT04058353

This study will evaluate the efficacy, safety and pharmacodynamics of elexacaftor (ELX, VX-445) in triple combination (TC) with tezacaftor (TEZ) and ivacaftor (IVA) in subjects with cystic fibrosis (CF) who are heterozygous for F508del and a gating or residual function mutation (F/G and F/RF genotypes).

Cystic Fibrosis

Vertex Pharmaceuticals Incorporated271 participantsStarted Aug 2019

Birmingham, Alabama, United States • Tucson, Arizona, United States • Long Beach, California, United States +90 more locations

Maxigesic IV Phase 3 Bunionectomy Study

A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Find Trials by Condition in Texas

A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes

Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)

Dysport in Hallux Abducto Valgus (HAV) Phase IIa

A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.

A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension

Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

Viable Allograft Supplemented Disc Regeneration in the Treatment of Patients With Low Back Pain

A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia

Product Performance of a New Silicone Hydrogel Contact Lens

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Long Term Study of Canakinumab (ACZ885) in Patients With Gout